Edition:
United States

Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

107.50GBp
21 Feb 2017
Change (% chg)

0.00 (+0.00%)
Prev Close
107.50
Open
107.50
Day's High
--
Day's Low
--
Volume
21,013
Avg. Vol
3,113
52-wk High
255.00
52-wk Low
88.00

AKR.L

Chart for AKR.L

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)
No analyst recommendations are available for AKR.L.

Overall

Beta: 1.54
Market Cap(Mil.): £7.37
Shares Outstanding(Mil.): 7.12
Dividend: --
Yield (%): --

Financials

  AKR.L Industry Sector
P/E (TTM): -- 44.59 29.71
EPS (TTM): -0.88 -- --
ROI: -81.08 -3.18 12.94
ROE: -81.08 5.86 14.09

BRIEF-Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge

* US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device

Feb 16 2017

BRIEF-Akers Biosciences prices 1.6 mln share offering at $1.20 per share

* Akers Biosciences announces pricing of public offering of 1,667,000 shares and 833,500 warrants

Jan 09 2017

BRIEF-Akers Biosciences files for potential stock shelf, size not disclosed

* Files for potential stock shelf; size not disclosed - sec filing Source text : http://bit.ly/2fGeOku Further company coverage:

Nov 16 2016

BRIEF-Akers Biosciences reports Q3 earnings

* Akers Biosciences announces Q3 earnings Source text for Eikon: Further company coverage:

Nov 14 2016

BRIEF-Akers Biosciences issued european patent protection for breath ketone detector

* Akers biosciences issued european patent protection for breath ketone detector Source text for Eikon: Further company coverage:

Nov 10 2016

More From Around the Web

Earnings vs. Estimates